These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526 [TBL] [Abstract][Full Text] [Related]
5. Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae. Castanheira M; Huband MD; Mendes RE; Flamm RK Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652234 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility pattern of Sethi S; Sharma M; Kumar S; Singhal L; Gautam V; Ray P Indian J Med Res; 2020 Dec; 152(6):656-661. PubMed ID: 34145106 [TBL] [Abstract][Full Text] [Related]
7. Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values. Vialichka A; Biagi M; Meyer K; Wu T; Shajee A; Tan X; Wenzler E Microbiol Spectr; 2022 Aug; 10(4):e0270521. PubMed ID: 35862943 [TBL] [Abstract][Full Text] [Related]
8. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985 [No Abstract] [Full Text] [Related]
9. Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole on Montoya-Hinojosa EI; Salazar-Sesatty HA; Alvizo-Baez CA; Terrazas-Armendariz LD; Luna-Cruz IE; Alcocer-González JM; Villarreal-Treviño L; Flores-Treviño S Expert Rev Anti Infect Ther; 2023 Feb; 21(2):213-223. PubMed ID: 36625029 [TBL] [Abstract][Full Text] [Related]
13. Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid. Correa-Ruiz A; Girón R; Buendía B; Medina-Pascual MJ; Valenzuela C; López-Brea M; Sáez-Nieto JA Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):649-54. PubMed ID: 23528342 [TBL] [Abstract][Full Text] [Related]
14. Clonality and Antimicrobial Susceptibility of Burkholderia cepacia complex Isolates Collected from Cystic Fibrosis Patients during 1998-2013 in Bern, Switzerland. Lupo A; Isis E; Tinguely R; Endimiani A New Microbiol; 2015 Apr; 38(2):281-8. PubMed ID: 25938755 [TBL] [Abstract][Full Text] [Related]
15. Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients. Bosch A; Miñán A; Vescina C; Degrossi J; Gatti B; Montanaro P; Messina M; Franco M; Vay C; Schmitt J; Naumann D; Yantorno O J Clin Microbiol; 2008 Aug; 46(8):2535-46. PubMed ID: 18550747 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients. Díez-Aguilar M; Ekkelenkamp M; Morosini MI; Merino I; de Dios Caballero J; Jones M; van Westreenen M; Tunney MM; Cantón R; Fluit AC Int J Antimicrob Agents; 2019 Jan; 53(1):84-88. PubMed ID: 30240837 [TBL] [Abstract][Full Text] [Related]